Roche Taps MitoSciences’ Assays to Study Mitochondrial Toxicity in Kinase Inhibitors | GenomeWeb
MitoSciences said last week it will use its cell-based MitoTox technology in a collaboration with Roche to generate mitochondrial toxicity profiles for more than 100 known kinase inhibitors.
Under the terms of the agreement, Roche will provide the compound library and previously gathered in vitro and in vivo data, and MitoSciences will use MitoTox to provide a more detailed set of mechanistic in vitro data for a broad range of mitochondrial toxicity endpoints.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.